Chakravarthy, U., Harding, S. P., Rogers, C. A., Downes, S. M., Lotery, A. J., Culliford, L. A., . . . investigators, I. s. (2013). Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial. Lancet, 382(9900), 1258. https://doi.org/10.1016/S0140-6736(13)61501-9
Chicago Style (17th ed.) CitationChakravarthy, Usha, Simon P. Harding, Chris A. Rogers, Susan M. Downes, Andrew J. Lotery, Lucy A. Culliford, Barnaby C. Reeves, and IVAN study investigators. "Alternative Treatments to Inhibit VEGF in Age-related Choroidal Neovascularisation: 2-year Findings of the IVAN Randomised Controlled Trial." Lancet 382, no. 9900 (2013): 1258. https://doi.org/10.1016/S0140-6736(13)61501-9.
MLA (9th ed.) CitationChakravarthy, Usha, et al. "Alternative Treatments to Inhibit VEGF in Age-related Choroidal Neovascularisation: 2-year Findings of the IVAN Randomised Controlled Trial." Lancet, vol. 382, no. 9900, 2013, p. 1258, https://doi.org/10.1016/S0140-6736(13)61501-9.